首页> 外文期刊>Molecular informatics >Computational Study of Drugs by Integrating Omics Data with Kernel Methods
【24h】

Computational Study of Drugs by Integrating Omics Data with Kernel Methods

机译:通过将组学数据与内核方法集成在一起的药物计算研究

获取原文
获取原文并翻译 | 示例
           

摘要

With the rapid development of genomic and che-mogenomic techniques, many omics data sources for drugs have been publicly available. These data sources illustrate drug's biological function in the living cell from different levels and different aspects. One straightforward idea is to learn understandable rules via computational models and algorithms to mine and integrate these data sources. Here, we review our recent efforts on developing kernel-based methods to integrate drug related omics data sources. Three promising applications of our framework are shown to predict drug targets, assign drug's ATC-code annotation, and reveal drug repositioning. We demonstrate that data integration does provide more information and improve the accuracy by recovering more experimentally observed target proteins, ATC-codes, and drug repositioning. Importantly, data integration can indicate novel predictions which are supported by database search and functional annotation analysis and worthy of further experimental validation. In conclusion, kernel methods can efficiently integrate heterogeneous data sources to computationally study drugs, and will promote the further research in drug discovery in a low-cost way.
机译:随着基因组学和化学基因组学技术的迅速发展,许多药物学的组学数据来源已经公开可用。这些数据来源从不同水平和不同方面说明了药物在活细胞中的生物学功能。一个简单的想法是通过计算模型和算法来学习可理解的规则,以挖掘和集成这些数据源。在这里,我们回顾了我们最近在开发基于核的方法以整合与药物相关的组学数据源的工作。我们的框架的三个有希望的应用程序可以预测药物目标,分配药物的ATC代码注释并揭示药物的重新定位。我们证明,数据整合确实可以提供更多信息,并且可以通过回收更多实验观察到的靶蛋白,ATC代码和药物重新定位来提高准确性。重要的是,数据集成可以表明数据库搜索和功能注释分析支持的新颖预测,值得进一步的实验验证。总之,核方法可以有效地整合异构数据源以进行药物研究,并将以低成本促进对药物发现的进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号